Whats changed one year after the London Drugs cyberattack

A year after a sophisticated cyberattack, London Drugs still faces challenges as personal data from the breach remains available on the dark web. Threat analyst Luke Connolly notes that the company has made strides in improving its cybersecurity measures, focusing on employee training and policy enhancements. The attack, linked to the LockBit cybercriminal group, underscores the risks businesses face from ransomware threats. London Drugs declined a $25 million ransom demand, demonstrating a commitment to not negotiating with criminals. Connolly states that the data breach poses risks not just to the company but also to consumers, who must remain vigilant against identity theft.

He suggests that individuals employ complex passwords and multi-factor authentication to mitigate risks. The incident highlights the ongoing need for robust cybersecurity practices across industries. London Drugs’ experience serves as a cautionary tale for other businesses in the region.